½ÃÀ庸°í¼­
»óǰÄÚµå
1518905

Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ º¯ÇõÀû ¼ºÀåÀ» ÁÖµµÇÏ´Â ¼¼°è ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ºÎ¹® - ¼¼°è ¿¹Ãø(2024-2028³â)

Remote Patient Monitoring Sector Driving Transformational Growth through Strategic Partnerships: Forecast-Global, 2024-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 62 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

»ê¾÷ À¶ÇÕ°ú µðÁöÅÐÈ­·Î °æÀï ȯ°æÀº ´õ¿í Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)Àº ÀÓ»óÀǰ¡ ȯÀÚÀÇ »ýü µ¥ÀÌÅÍ¿Í ÇൿÀ» ¿ø°ÝÀ¸·Î ¼öÁýÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÈ ÀåÄ¡¿Í IT ÀÎÇÁ¶ó¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ÀÎÇÁ¶ó¿¡´Â ¼ÒÇÁÆ®¿þ¾î, °ÔÀÌÆ®¿þÀÌ, Ç÷§Æû, µ¥ÀÌÅÍ Àü¼Û ¹× °ü¸® ½Ã½ºÅÛ, ³×Æ®¿öÅ© µîÀÌ Æ÷ÇԵ˴ϴÙ. ½º¸¶Æ®Æù, ½º¸¶Æ®¿öÄ¡, ÇÇÆ®´Ï½º Æ®·¡Ä¿¿Í °°Àº ¼ÒºñÀÚ ¿þ¾î·¯ºíµµ À¯»çÇÑ µ¥ÀÌÅÍ(½É¹Ú¼ö, ¼ö¸éÀÇ Áú, À̵¿¼º µî)¸¦ Á¦°øÇÒ ¼ö ÀÖÁö¸¸, À̹ø Á¶»ç¿¡¼­´Â Àϰü¼º°ú Á¤È®µµ°¡ ³ô´Ù´Â ÀÌÀ¯·Î ÀÓ»óÀǸ¦ À§ÇÑ RPM ±â¼ú¿¡¸¸ ÃÊÁ¡À» ¸ÂÃè½À´Ï´Ù.

ÀÌ ¼¼°è ºÐ¼®Àº µ¥ÀÌÅÍ °¡¿ë¼ºÀÌ ³ô°í ÀÌ Áö¿ª ½ºÅ¸Æ®¾÷ÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå°ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ´Â ¹Ì±¹À» Áß½ÉÀ¸·Î ÁÖ¿ä ½ÃÀå¿¡ ´ëÇÑ °³¿ä¸¦ Á¦°øÇϸç, RPM »ê¾÷Àº Áö¼ÓÀûÀÎ °ü¸®¿Í Á¦Ç° ¹× ¼­ºñ½º Á¦°ø ¹üÀ§¿¡ µû¶ó ±¸ºÐµË´Ï´Ù. ±â¾÷µéÀº ƯÁ¤ ÄÉ¾î Æ÷ÀÎÆ®¿¡ ´ëÇÑ ÀÏ·ÃÀÇ Á¦Ç°À» Á¦°øÇϱ⵵ Çϰí, º¸´Ù ±¤¹üÀ§ÇÑ ¿ëµµÀÇ Á¦Ç° ¹× ¼­ºñ½º¿¡ ƯȭµÈ Á¦Ç°À» Á¦°øÇϱ⵵ ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç° °£ÀÇ Â÷º°È­°¡ ÁöÀûµÇ°í ÀÖÁö¸¸, ¾÷°è´Â ÁÖ·Î ÀÌ·¯ÇÑ Á¦Ç° ¹× ¼­ºñ½º¸¦ ¹øµé ¼Ö·ç¼ÇÀ¸·Î ÆÇ¸ÅÇϱ⠶§¹®¿¡ Frost & SullivanÀº Á¦Ç° ¼¼ºÐÈ­¿¡ ´ëÇÑ ¿¹ÃøÀ» Á¦°øÇÏÁö ¾Ê½À´Ï´Ù.

ÀÌ Á¾ÇÕÀûÀÎ ºÐ¼®À» ÅëÇØ ÀÇ·áÁøÀº º¯È­ÇÏ´Â RPM ȯ°æÀ» ÇìÃijª°¥ ¼ö ÀÖ´Â Áß¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖÀ¸¸ç, ¼ºÀå ±âȸ, Áö¿ª µ¿Çâ ¹× Àü·«Àû ÀÇ»ç°áÁ¤¿¡ ÇʼöÀûÀÎ ºñÁî´Ï½º ¸ðµ¨ ºÐ¼®À» È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Àü·«Àû Çʼö ¿ä°Ç

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
  • The Strategic Imperative 8(TM)
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¾÷°è¿¡ ´ëÇÑ ÁÖ¿ä Àü·«Àû Çʼö ¿ä°ÇÀÇ ¿µÇâ
  • Growth Pipeline Engine(TM)À» °¡¼ÓÇÏ´Â ¼ºÀå ±âȸ

¼ºÀå ±âȸ ºÐ¼®

  • ºÐ¼® ¹üÀ§
  • ¾÷°è ¼¼ºÐÈ­
  • ¾÷°è ¼¼ºÐÈ­ : Áö¼ÓÀûÄɾî
  • ¾÷°è ¼¼ºÐÈ­ : Á¦Ç° ¹× ¼­ºñ½º
  • ÁÖ¿ä °æÀï»ç
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ±¸Á¶
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ºÅ¸Æ®¾÷ ±â¾÷ : ÅõÀÚ »óȲ
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ : º¸ÇèÀÚÀÇ ¿ªÇÒ
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ : º¸ÇèÀÚ ÆÄÆ®³Ê½Ê
  • FDA ÀçÅÃÄ¡·á ÀÌ´Ï¼ÅÆÁ
  • ¼ºÀå ÁöÇ¥
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¿¹ÃøÀÇ ÀüÁ¦Á¶°Ç
  • ¸ÅÃâ ¿¹Ãø
  • Áö¼ÓÀû Äɾ, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • °¡°Ý µ¿Çâ°ú ¿¹Ãø ºÐ¼®
  • °æÀï ȯ°æ
  • ¸ÅÃâ Á¡À¯À²
  • ¸ÅÃâ Á¡À¯À² ºÐ¼®
  • °æÀï ȯ°æ - »ç·Ê ¿¬±¸

¼ºÀå ±âȸ ºÐ¼® : ¸¸¼º±â Äɾî

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ ºÐ¼® : °úµµ±âÀû Äɾî

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ ºÐ¼® : ÁßȯÀÚ Ä¡·á

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ

  • ¼ºÀå ±âȸ 1 : Á¤½Å °Ç°­ ¹× Çൿ °Ç°­
  • ¼ºÀå ±âȸ 2 : ¸é¿ª Áúȯ
  • ¼ºÀå ±âȸ 3 : ¿©¼º °Ç°­¿¡¼­ÀÇ ÅëÁõ °ü¸®

´ÙÀ½ ´Ü°è

LSH 24.07.30

Industry Convergence and Digitalization Intensify the Competitive Environment

Remote patient monitoring (RPM) encompasses devices and IT infrastructure designed to enable clinicians to collect and monitor patients' biometric data and behaviors remotely. This infrastructure includes software, gateways, platforms, data transmission and management systems, and networks. While consumer-grade wearables, including smartphones, smartwatches, and fitness trackers, can provide similar data (e.g., heart rate, sleep quality, mobility), this study focuses exclusively on clinician-intended RPM technologies due to their higher consistency and accuracy.

RPM differs from telehealth, which primarily involves communication via video or audio between patients and clinicians. Instead, RPM focuses on the remote collection of vital statistics, biochemistry, and cardiac rhythms, along with related products and services that transmit and provide clinical insights into the collected data. Despite the integral role of EMR/EHR technology in RPM workflows, this study excludes these technologies from market calculations, treating them as separate entities.

Many consumer-grade wearables (e.g., smartphones, smartwatches, and fitness trackers) provide data similar to devices that are part of the RPM industry (e.g., heart rate and rhythm, sleep length and quality, and mobility). However, for this analysis, we limit the definition of RPM to technologies specifically intended for use by clinicians to monitor patients. While it is possible to use consumer-grade devices in medical RPM in the future, there is a wider variance in their consistency and accuracy, so clinicians do not currently widely accept them.

This global analysis provides an overview of major markets, primarily the United States due to the greater availability of data and significant growth and innovation driven by start-ups in the region. The RPM industry is segmented by care continuum and the range of products and services offered. Companies may offer a suite of products for specific points of care or specialize in products or services with broader applications. While the differentiation among these offerings is noted, Frost & Sullivan does not provide forecasts on product segmentation, as the industry predominantly sells these products and services as bundled solutions.

The comprehensive analysis equips healthcare stakeholders with critical insights to navigate the evolving RPM landscape, highlighting growth opportunities, regional trends, and business model analyses essential for strategic decision-making.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Remote Patient Monitoring Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Industry Segmentation
  • Industry Segmentation: Care Continuum
  • Industry Segmentation: Products and Services
  • Key Competitors
  • Remote Patient Monitoring Structure
  • Remote Patient Monitoring Start-ups: Investment Landscape
  • Remote Patient Monitoring: Payer's Role
  • Remote Patient Monitoring: Payer Partnerships
  • FDA Health Care at Home Initiative
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Care Continuum
  • Revenue Forecast by Region
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • Revenue Share
  • Revenue Share Analysis
  • Competitive Environment-Case Studies

Growth Opportunity Analysis: Chronic Care

  • Growth Metrics
  • Revenue Forecast
  • Forecast Analysis

Growth Opportunity Analysis: Transitional Care

  • Growth Metrics
  • Revenue Forecast
  • Forecast Analysis

Growth Opportunity Analysis: Critical Care

  • Growth Metrics
  • Revenue Forecast
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: Mental and Behavioral Health
  • Growth Opportunity 2: Immune Diseases
  • Growth Opportunity 3: Pain Management in Women's Health

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦